Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-08

Clinical Trial Update: Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating CLORazepate for acute migraine treatment in the emergency room has been terminated. The update does not report efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLORazepate

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Migraine, Migraine Without Aura | Phase 3 | Status: TERMINATED